BusinessProLynx extends lead in half-life extension platform technology – Shows primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery systemBy Nasdaq OMXApr 3, 2018, 1:02 PM UTC
BusinessAdvanced Medical Isotope Corporation (ADMD) Announces Corporate Name Change to Vivos Inc., and Ticker Symbol Change to RDGLBy Nasdaq OMXJan 2, 2018, 2:01 PM UTC
BusinessGlobal Hydrogel Market to be worth US$17,487.6 mn by 2024 - Transparency Market ResearchBy Nasdaq OMXNov 13, 2017, 9:13 AM UTC
BusinessProLynx announces SBIR grant award to develop novel technology for dual receptor agonistsBy Nasdaq OMXSep 25, 2017, 1:00 PM UTC
BusinessNew technology from Response Scientific offers solution to opioid drug epidemicBy Nasdaq OMXJun 28, 2017, 5:30 PM UTC
BusinessProLynx announces collaboration with Daiichi Sankyo to evaluate drug delivery system in the eyeBy Nasdaq OMXJun 19, 2017, 1:00 PM UTC
BusinessProLynx announces PLX039, a hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonistBy Nasdaq OMXJun 12, 2017, 1:00 PM UTC
BusinessProLynx issued US patent for cleavable linker technology on hydrogelsBy Nasdaq OMXMay 31, 2017, 12:03 AM UTC
